Loading clinical trials...
Loading clinical trials...
An Open-label, Randomised Pilot Study Comparing the Efficacy, Safety and Tolerability of Raltegravir With Protease Inhibitor-based Therapy in Treatment-naïve, HIV/Hepatitis C Co-infected Injecting Drug Users Receiving Methadone
Conditions
Interventions
Raltegravir
Atazanavir/Ritonavir
Locations
2
Ireland
Department of Genitourinary Medicine and Infectious Diseases, St. James's Hospital
Dublin, Ireland
Mater Misericordiae University Hospital
Dublin, Ireland
Start Date
August 1, 2010
Primary Completion Date
December 1, 2012
Completion Date
December 1, 2012
Last Updated
July 21, 2011
NCT06694805
NCT04142047
NCT06953479
NCT07428330
NCT07225530
NCT05897099
Lead Sponsor
St. James's Hospital, Ireland
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions